安进:每月注射马利肽的24周研究显示2型糖尿病患者糖化血红蛋白与体重均现强劲且具临床意义的下降

美股速递
Jan 13

安进公司公布的一项为期24周的研究结果显示,在2型糖尿病患者中,每月注射一次马利肽(Maritide)能够显著且具有临床意义地降低患者的糖化血红蛋白(HbA1c)水平和体重。该研究数据展现出积极的治疗效果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10